SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001654954-18-013924
Filing Date
2018-12-13
Accepted
2018-12-13 17:00:44
Documents
1
Period of Report
2018-08-02
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K/A vtgn8ka.htm 8-K/A 23798
  Complete submission text file 0001654954-18-013924.txt   24962
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K/A | Act: 34 | File No.: 001-37761 | Film No.: 181233814
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1